Clinical Trial Update: Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients

View source ↗

Summary

This clinical trial investigates using CMV-specific T cell immunity to guide prophylaxis and prevent CMV disease in lung transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Diseases

Snippet

Sponsor: University of Miami | Conditions: Lung Diseases | Status: RECRUITING